🇺🇸 FDA
Pipeline program

Exploratory Bioavailability of Three Formulations of Gliclazide MR Tablets 120 mg (I.R.I.S.) in Healthy Volunteers Under Fed Conditions (High Fat High Calorie Meal and Standard Meal).

S005190-213

Phase 1 other active

Quick answer

Exploratory Bioavailability of Three Formulations of Gliclazide MR Tablets 120 mg (I.R.I.S.) in Healthy Volunteers Under Fed Conditions (High Fat High Calorie Meal and Standard Meal). for No medical condicion. is a Phase 1 program (other) at The George Institute with 1 ClinicalTrials.gov record(s).

Program details

Company
The George Institute
Indication
No medical condicion.
Phase
Phase 1
Modality
other
Status
active

Clinical trials